Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[HL-A antigenicity in bladder tumors]

G Jakse, F Hofstädter

    Helvetica Chirurgica Acta
    |July 1, 1978
    PubMed
    Summary
    This summary is machine-generated.

    Loss of antigenicity in bladder tumors, identified by the specific red cell adherence test (SRCA), correlates with more aggressive tumor behavior and secondary occurrences. This finding may inform future bladder cancer therapies.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Correction to: The natural course of pT2 prostate cancer with positive surgical margin: predicting biochemical recurrence.

    World journal of urology·2020
    Same author

    [Autopsy in oncology : Treatment validation in cancer centers and clinical cancer registries].

    Der Pathologe·2017
    Same author

    Screening-relevant age threshold of 70 years and older is a stronger determinant for the choice of adjuvant treatment in breast cancer patients than tumor biology.

    Breast cancer research and treatment·2017
    Same author

    [Not Available].

    Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]·2016
    Same author

    4-IHC classification of breast cancer subtypes in a large cohort of a clinical cancer registry: use in clinical routine for therapeutic decisions and its effect on survival.

    Breast cancer research and treatment·2015
    Same author

    Adjuvant endocrine therapy in pre- versus postmenopausal patients with steroid hormone receptor-positive breast cancer: results from a large population-based cohort of a cancer registry.

    Journal of cancer research and clinical oncology·2015

    Area of Science:

    • Oncology
    • Immunology
    • Urology

    Context:

    • Transitional cell carcinoma (TCC) is the most common type of bladder cancer.
    • Transurethral resection (TUR) is a standard treatment for non-invasive bladder tumors.
    • Tumor antigenicity is a potential biomarker for disease progression.

    Purpose:

    • To investigate the correlation between tumor antigenicity and the biological behavior of bladder tumors.
    • To assess the prognostic value of antigen loss in patients treated with TUR.
    • To explore potential therapeutic implications of antigenicity assessment in bladder cancer management.

    Summary:

    • 30 patients with stage O and A papillary transitional bladder tumors underwent transurethral resection (TUR).
    • Tumor specimens were analyzed for antigenicity using the specific red cell adherence test (SRCA).

    Related Experiment Videos

  • A correlation was observed between the loss of antigenicity and the subsequent development of tumors exhibiting more aggressive biological behavior during 4-17 years of follow-up.

    • Impact:

    • Identifies loss of antigenicity as a potential indicator of aggressive bladder cancer recurrence.
    • Suggests that antigenicity assessment could aid in risk stratification for bladder tumor patients.
    • Highlights potential avenues for developing targeted therapies based on tumor immunophenotype.